163 related articles for article (PubMed ID: 33830865)
21. Integrated multi-omics analysis of the clinical relevance and potential regulatory mechanisms of splicing factors in hepatocellular carcinoma.
Zhao YJ; Wu LY; Pang JS; Liao W; Chen YJ; He Y; Yang H
Bioengineered; 2021 Dec; 12(1):3978-3992. PubMed ID: 34288818
[TBL] [Abstract][Full Text] [Related]
22. LncRNA ROR1‑AS1 high expression and its prognostic significance in liver cancer.
Zhang Z; Wang S; Yang F; Meng Z; Liu Y
Oncol Rep; 2020 Jan; 43(1):55-74. PubMed ID: 31746401
[TBL] [Abstract][Full Text] [Related]
23. Prognostic potential of PRPF3 in hepatocellular carcinoma.
Liu Y; Yang Y; Luo Y; Wang J; Lu X; Yang Z; Yang J
Aging (Albany NY); 2020 Jan; 12(1):912-930. PubMed ID: 31926109
[TBL] [Abstract][Full Text] [Related]
24. A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.
Guo C; Gao C; Zhao D; Li J; Wang J; Sun X; Liu Q; Hao L; Greenaway FT; Tian Y; Liu S; Sun MZ
J Exp Clin Cancer Res; 2020 Apr; 39(1):70. PubMed ID: 32326970
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value and underlying mechanism of KIAA0101 in hepatocellular carcinoma: database mining and co-expression analysis.
Xu W; Wang X; Wu X; Yu S; Xiong J; Sang X; Zheng Y; Zhang Z
Aging (Albany NY); 2020 Aug; 12(16):16420-16436. PubMed ID: 32855364
[TBL] [Abstract][Full Text] [Related]
26. CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
Zhong X; Kan A; Zhang W; Zhou J; Zhang H; Chen J; Tang S
Aging (Albany NY); 2019 Aug; 11(15):5483-5497. PubMed ID: 31375643
[TBL] [Abstract][Full Text] [Related]
27. Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein.
Jin YJ; Aycheh HM; Han S; Chamberlin J; Shin J; Byun S; Lee Y
BMC Med Genomics; 2020 Dec; 13(Suppl 11):194. PubMed ID: 33371894
[TBL] [Abstract][Full Text] [Related]
28. Transcript levels of spindle and kinetochore-associated complex 1/3 as prognostic biomarkers correlated with immune infiltrates in hepatocellular carcinoma.
Yu DC; Chen XY; Li X; Zhou HY; Yu DQ; Yu XL; Hu YC; Zhang RH; Zhang XB; Zhang K; An JD
Sci Rep; 2021 May; 11(1):11165. PubMed ID: 34045512
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells.
Zhang D; Wang Y; Dai Y; Wang J; Suo T; Pan H; Liu H; Shen S; Liu H
Tumour Biol; 2015 Mar; 36(3):2077-85. PubMed ID: 25391428
[TBL] [Abstract][Full Text] [Related]
30. Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma.
Huang R; Yan G; Sun H; Zhang J; Song D; Kong R; Yan P; Hu P; Xie A; Wang S; Zhuang J; Yin H; Meng T; Huang Z
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32627826
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
32. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
[TBL] [Abstract][Full Text] [Related]
33. RBM25 binds to and regulates alternative splicing levels of
Tian X; Zhou G; Li H; Zhang X; Zhao L; Zhang K; Wang L; Liu M; Liu C; Yang P
PeerJ; 2023; 11():e16312. PubMed ID: 37953772
[TBL] [Abstract][Full Text] [Related]
34. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
35. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
[TBL] [Abstract][Full Text] [Related]
36. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
37. The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA.
Han L; Huang C; Zhang S
Liver Int; 2019 Nov; 39(11):2190-2203. PubMed ID: 31365778
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
[TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
40. Identification of GRB2 and GAB1 coexpression as an unfavorable prognostic factor for hepatocellular carcinoma by a combination of expression profile and network analysis.
Zhang Y; Li Z; Yang M; Wang D; Yu L; Guo C; Guo X; Lin N
PLoS One; 2013; 8(12):e85170. PubMed ID: 24391994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]